CONVERGENCE BIO Trademark
CONVERGENCE BIO is a USPTO trademark filed by Convergence Bio, Inc.. Status: Pending.
Trademark Facts
| Mark | CONVERGENCE BIO |
|---|---|
| Serial Number | 98576548 |
| Status | Pending |
| Filing Date | 2024-05-30 |
| Mark Type | Word |
| Nice Classes | 001 (Chemicals), 005 (Pharmaceuticals), 042 (Software & IT) |
| Owner | Convergence Bio, Inc. |
| Attorney of Record | Ryan S. Hilbert |
| Prosecution Events | 31 |
| Latest Event | CNEA on 2026-04-29 |
Goods & Services
Class 001: assays and reagents for use in scientific and biomedical research; Class 005: pharmaceutical preparations, vaccines, and medical therapeutic pharmaceuticals for the prevention and treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; medical therapeutics in the form of medicines and medical preparations for the prevention and treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations, vaccines, and medical therapeutic pharmaceuticals for the prevention and treatment of blood disorders, bone disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; medical therapeutics in the form of medicines and medical preparations for the prevention and treatment of blood disorders, bone disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; vaccines for human use; pharmaceutical preparations, vaccines, and medical therapeutic pharmaceuticals for improving the aging nervous system, aging cardiovascular system, aging respiratory system, aging gastrointestinal system, aging reproductive system, aging renal system, aging endocrine system, aging lymphatic system, aging immune system, aging muscular system, aging skeletal system, aging integumentary system, and for boosting energy, boosting vitality, promoting sleep, alleviating anxiety, enhancing memory and cognitive ability, and weight loss; medical therapeutics in the form of medicines and medical preparations for improving the aging nervous system, aging cardiovascular system, aging respiratory system, aging gastrointestinal system, aging reproductive system, aging renal system, aging endocrine system, aging lymphatic system, aging immune system, aging muscular system, aging skeletal system, aging integumentary system, and for boosting energy, boosting vitality, promoting sleep, alleviating anxiety, enhancing memory and cognitive ability, and weight loss; nutritional and dietary supplements for improving the aging nervous system, aging cardiovascular system, aging respiratory system, aging gastrointestinal system, aging reproductive system, aging renal system, aging endocrine system, aging lymphatic system, aging immune system, aging muscular system, aging skeletal system, aging integumentary system, and for boosting energy, boosting vitality, promoting sleep, alleviating anxiety, enhancing memory and cognitive ability, and weight loss; Class 042: research and development services in the field of pharmaceutical preparations, vaccines and therapeutic drugs for the prevention and treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; research and development services of new pharmaceutical preparations, vaccines, medical therapeutics, and medical therapeutic pharmaceuticals relating to therapeutic antibodies and pharmaceuticals, and research and development of technology in the field of therapeutic antibodies, pharmaceuticals and biopharmaceuticals; research and development of new pharmaceutical preparations, vaccines, medical therapeutics, and medical therapeutic pharmaceuticals relating to therapeutic modalities for treatment of aging nervous system, aging cardiovascular system, aging respiratory system, aging gastrointestinal system, aging reproductive system, aging renal system, aging endocrine system, aging lymphatic system, aging immune system, aging muscular system, aging skeletal system, aging integumentary system, and for boosting energy, boosting vitality, promoting sleep, alleviating anxiety, enhancing memory and cognitive ability, and weight loss; development of pharmaceutical preparations, vaccines and medicines; medical research for development of therapeutic modalities for treatment of diseases; pharmaceutical, vaccine, medical therapeutic, and medical therapeutic pharmaceutical drug development and discovery; clinical studies in the nature of medical research services and conducting clinical trials for others; clinical studies, namely, clinical research in the field of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; preclinical and clinical development of therapeutic products, namely, development of medicines, pharmaceutical preparations, vaccines, medical therapeutics, and medical therapeutic pharmaceuticals
Recent Prosecution Activity
| Date | Document | Type |
|---|---|---|
| 2026-01-27 | Application Extension to Response | ELR |
| 2025-10-27 | Final Action | FREF |
| 2025-07-03 | Amendment and Mail Process Complete | AMC |
| 2025-07-02 | Response to Office Action | ROA |
| 2025-07-02 | Change Address or Representation Form | CAR |
| 2025-03-05 | Application Extension to Response | ELR |
USPTO Refusals on Record
- indefinite_identification